PubMed · 1992 · 14 citations · 0 references
MedicineOphthalmologyPharmacologyOcular Drug DeliveryOcular PharmacologyPharmacodynamicsFungal Eye InfectionsOcular Penetration EnhancementOcular PharmacodynamicsOcular PharmacokineticsRetinal PharmacotherapyFluconazole TherapyIntraocular DistributionIntraocular PenetrationIntraocular PharmacokineticsIntraocular ToxicityRetinal Drug SafetySafety LimitsVitreous Drug Distribution
The intraocular concentration of fluconazole was measured in nonvitrectomized and vitrectomized eyes after an intravenous administration of 5 or 25 mg/kg fluconazole in albino rabbits. Respective fluconazole concentrations in the aqueous, vitreous and serum 1 hour after administration were 2.87, 1.72 and 4.60 micrograms/ml at 5 mg/kg administration, and 14.93, 7.05 and 20.63 micrograms/ml at 25 mg/kg administration, indicating high and dose-dependent intraocular penetration of fluconazole. Intraocular penetration of intravenously administered fluconazole was moderately, not very much, enhanced by vitrectomy. The in-vitro electroretinogram (ERG) remained unchanged after perfusion with 20 micrograms/ml of fluconazole. The in-vivo ERG and the visual evoked potential was unchanged after the daily administration of 25 mg/kg fluconazole for 8 days. The toxicity of fluconazole on the retina would be low and within safety limits so far as it is used at clinical dosage. Fluconazole may have a place in the treatment of fungal ocular infections.